Germany
Japan
United Kingdom
China
Antibodies
View as table Download
USD 379.00
In Stock
Recombinant Anti-CD52 (Clone Campath-1H)
| Applications | ELISA, FC, IHC, WB |
| Reactivities | Human, Monkey |
| Conjugation | Unconjugated |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-CD52 (Clone Campath-1H)
| Applications | ELISA, FC, IHC, WB |
| Reactivities | Human, Monkey |
| Conjugation | Unconjugated |
| Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-p53 (Clone PAb421)
| Applications | ELISA, IF, IHC, IP, WB |
| Reactivities | Human, Monkey, Mouse, Rabbit, Rat |
| Conjugation | Unconjugated |
Recombinant Anti-p53 (Clone PAb421)
| Applications | ELISA, IF, IHC, IP, WB |
| Reactivities | Human, Monkey, Mouse, Rabbit, Rat |
| Conjugation | Unconjugated |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG2a format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-CD52 (Clone YTH 34.5-G2b (Campath-1G))
| Applications | ELISA, FC, IHC, WB |
| Reactivities | Human, Monkey |
| Conjugation | Unconjugated |
| Modifications | This is a chimeric mouse antibody, based on the original rat IgG2b format, created for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-CD52 (Clone YTH 34.5-G2b (Campath-1G))
| Applications | ELISA, FC, IHC, WB |
| Reactivities | Human, Monkey |
| Conjugation | Unconjugated |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG2b format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-CD52 (Clone YTH 34.5-G2b (Campath-1G))
| Applications | ELISA, FC, IHC, WB |
| Reactivities | Human, Monkey |
| Conjugation | Unconjugated |
Recombinant Anti-CD40 (Clone 5D12)
| Applications | ELISA, FC, IHC, IP |
| Reactivities | Human, Monkey, Cynomolgus |
| Conjugation | Unconjugated |
Recombinant Anti-CD40 (Clone 5D12)
| Applications | ELISA, FC, IHC, IP |
| Reactivities | Human, Monkey, Cynomolgus |
| Conjugation | Unconjugated |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-CD257 (BAFF) (Clone Tabalumab)
| Applications | ELISA, FC, IF, IP, Neutralize, WB |
| Reactivities | Human, Monkey, Rabbit |
| Conjugation | Unconjugated |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-CD18 (Clone 1B4)
| Applications | ELISA, FC, IF, IP |
| Reactivities | Human, Monkey |
| Conjugation | Unconjugated |
Recombinant Anti-CD18 (Clone 1B4)
| Applications | ELISA, FC, IF, IP |
| Reactivities | Human, Monkey |
| Conjugation | Unconjugated |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. |
USD 420.00
4 Weeks
USD 420.00
4 Weeks
USD 420.00
4 Weeks
USD 420.00
4 Weeks
USD 399.00
In Stock
Active filters
Category
-
Antibodies
- Primary Antibodies
Reactivities
- Monkey
Applications
- ELISA
Clonalities
- Monoclonal
Filter by
Target Symbol
Antibody Hosts
Isotypes
Conjugates
Modifications
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (2)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG2b format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG2a format, for improved compatibility with existing reagents, assays and techniques. (1)
- This is a chimeric mouse antibody, based on the original rat IgG2b format, created for improved compatibility with existing reagents, assays and techniques. (1)
Assay Types
Assay Platforms
Families
Pathways
- MAPK signaling pathway (9)
- Colorectal cancer (8)
- Endometrial cancer (8)
- Focal adhesion (8)
- Pathways in cancer (8)
- Prostate cancer (8)
- Acute myeloid leukemia (7)
- Chemokine signaling pathway (7)
- Chronic myeloid leukemia (7)
- ErbB signaling pathway (7)
- Glioma (7)
- Insulin signaling pathway (7)
- Melanoma (7)
- Neurotrophin signaling pathway (7)
- Non-small cell lung cancer (7)
- Pancreatic cancer (7)
- Progesterone-mediated oocyte maturation (7)
- Renal cell carcinoma (7)
- mTOR signaling pathway (7)
- Thyroid cancer (6)
- Bladder cancer (5)
- Long-term depression (5)
- Long-term potentiation (5)
- Natural killer cell mediated cytotoxicity (5)
- Regulation of actin cytoskeleton (5)
- Vascular smooth muscle contraction (5)
- Tight junction (3)
- Adipocytokine signaling pathway (2)
- Antigen processing and presentation (2)
- Apoptosis (2)
- B cell receptor signaling pathway (2)
- Endocytosis (2)
- Fc epsilon RI signaling pathway (2)
- Fc gamma R-mediated phagocytosis (2)
- Jak-STAT signaling pathway (2)
- Prion diseases (2)
- Small cell lung cancer (2)
- Spliceosome (2)
- T cell receptor signaling pathway (2)
- Toll-like receptor signaling pathway (2)
- VEGF signaling pathway (2)
- Adherens junction (1)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (1)
- Basal cell carcinoma (1)
- Leukocyte transendothelial migration (1)
- Melanogenesis (1)
- Pathogenic Escherichia coli infection (1)
- Wnt signaling pathway (1)